Transfer to the clinic: refining forward programming of hPSCs to megakaryocytes for platelet production in bioreactors. (2021)
Attributed to:
Joint Wellcome and MRC Centre, ‘Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute’
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1182/bloodadvances.2020003236
PubMed Identifier: 33843988
Publication URI: http://europepmc.org/abstract/MED/33843988
Type: Journal Article/Review
Volume: 5
Parent Publication: Blood advances
Issue: 7
ISSN: 2473-9529